Cure Leukaemia’s Chairman since 2012, Ian Allen, has stepped down from his role after overseeing the transformation of the blood cancer charity during his seven-year tenure. Ian started his relationship with Cure Leukaemia as a volunteer in its early years before being appointed a Trustee and then part-time Chief Executive.
In 2012, Ian was named Cure Leukaemia Chairman and immediately made perhaps his most important decision in appointing the charity’s first full-time Chief Executive, James McLaughlin in the same year.
During the next seven years Ian oversaw the growth of Cure Leukaemia from a small regional organisation to the recent announcement of the charity’s nationwide expansion from January 2020.
Speaking about his time as Chairman Ian said:
“I have been immensely proud to have been Chairman of this fantastic charity, Cure Leukaemia. I started as a volunteer and I was immediately struck by the simplicity and impact of the charity’s model and, as a businessman, I could see how this could grow and grow as a result.
‘I was also struck by the spirit and passion of everyone associated with Cure Leukaemia and I was keen to help steer the charity in the right direction. Critical to this growth was the appointment of James McLaughlin as the charity’s first full-time CEO. James’ introduction drastically changed the way Cure Leukaemia operated and thought and this has been the catalyst for its recent success.
‘I joined a small regional charity and I leave it as a national organisation with global significance in the fight against blood cancer. Now it is time for fresh thinking and a new face to help take it to the next level. I would like to thank everyone associated with Cure Leukaemia; the staff, Trustees, fundraisers and most importantly the patients who have helped make Cure Leukaemia the charity it is today.’
Cure Leukaemia’s co-founder Professor Charlie Craddock CBE said:
“Ian’s impact on this charity has been immeasurable. Cure Leukaemia has been able to achieve significant success and growth since 2012 thanks to his tireless efforts, expert guidance and generosity.
‘As a result, Cure Leukaemia is now in a position to fund a globally significant trials acceleration programme with specialist research nurses employed in 12 centres across the UK from January 2020. This is progress we could never have envisaged when the charity was founded in 2003 and thousands of patients stand to benefit with potentially life-saving treatments for blood cancer.’
‘On a personal level, and on behalf of the patients who have benefitted and those who will benefit in the future I would like to offer my sincerest thanks to Ian and his family for all they have done for Cure Leukaemia and I wish him all the very best for the future.’
Cure Leukaemia is now taking applications for the vacant Chairman’s role and those interested should email email@example.com for more information.
How funds raised for Cure Leukaemia help save lives